Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing

New Elite Feature:   Find Similar Charts in Seconds

Learn How
Market News Market Pulse Stocks News ETF News Crypto News

Caribou Biosciences, Inc.

Contributing Author

Recent Articles by Caribou Biosciences, Inc.

Aug-13
Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update CRBU -5.29% GlobeNewswire
Jun-29
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference CRBU +5.36% GlobeNewswire
Jun-11
Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026 CRBU -7.26% GlobeNewswire
Jun-11
Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting CRBU -7.26% GlobeNewswire
May-27
Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference CRBU +6.94% GlobeNewswire
May-13
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference CRBU GlobeNewswire
May-12
Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting CRBU GlobeNewswire
May-07
Caribou Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update CRBU GlobeNewswire
May-05
Caribou Biosciences to Participate in the BofA Securities 2026 Health Care Conference CRBU GlobeNewswire
Mar-31
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy CRBU +10.47% GlobeNewswire
Mar-05
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update CRBU CRBU +6.43% GlobeNewswire
Feb-12
Caribou Biosciences to Participate in Upcoming Investor Conferences CRBU GlobeNewswire
Feb-04
Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT and CIBMTR CRBU GlobeNewswire
Dec-01
Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025 CRBU -8.76% GlobeNewswire
Nov-12
Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update CRBU CRBU -12.17% GlobeNewswire
Nov-03
Caribou Biosciences to Participate in Upcoming Investor Conferences CRBU CRBU -10.70% GlobeNewswire
Nov-03
Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma CRBU GlobeNewswire
Nov-03
Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies CRBU GlobeNewswire
Nov-02
Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma CRBU GlobeNewswire
Aug-25
Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference CRBU CRBU +6.38% GlobeNewswire
Aug-12
Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update CRBU CRBU +8.94% GlobeNewswire
May-28
Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference CRBU GlobeNewswire
May-08
Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update CRBU GlobeNewswire
May-06
Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference CRBU -12.16% GlobeNewswire
Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)